Tuesday, November 4, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Impinj Stock: Record Margins Fuel 20% Rally

Dieter Jaworski by Dieter Jaworski
July 31, 2025
in Stocks
0
Impinj Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Impinj shares surged over 20% yesterday, reaching $124.88 after the RFID specialist reported second-quarter earnings that substantially exceeded analyst expectations. The company posted earnings per share of $0.80, well above the forecasted $0.71, while revenue climbed to $97.9 million, surpassing the projected $93.75 million. Most impressive was Impinj’s adjusted EBITDA margin, which hit a quarterly record of 28.2%. The gross margin reached 60.4%, underscoring the company’s enhanced profitability as it benefits from growing demand for its higher-margin M800 chip generation and favorable wafer costs.

Outlook Signals Continued Growth

Looking ahead, Impinj provided an exceptionally strong forecast that caught analysts by surprise. For Q3 2025, the company projects earnings per share between $0.47 and $0.51, approximately 40% higher than analyst estimates of $0.35. Revenue is expected to range from $91 to $94 million, significantly above the $85.99 million experts had anticipated. Management highlighted expansion into the food sector as a key growth driver, particularly for products with expiration dates. With $260.5 million in liquid assets and Q2 free cash flow of $27.3 million, Impinj appears well-positioned for continued growth.

Ad

Impinj Stock: Buy or Sell?! New Impinj Analysis from November 4 delivers the answer:

The latest Impinj figures speak for themselves: Urgent action needed for Impinj investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 4.

Impinj: Buy or sell? Read more here...

Tags: Impinj
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
MGM Resorts Stock

MGM Resorts Stock: Record Q2 Fueled by Asian Success

DexCom Stock

DexCom Stock: Growth Slows Despite Positive Earnings

Carlisle Stock

Carlisle Stock: Shares Tumble Despite Record Earnings

Recommended

Hims & Hers Health Registered (A) Stock

Hims & Hers Shares Face Critical Test Amid Growth Concerns

3 weeks ago
Alphabet Stock

Alphabet Shatters Revenue Records as AI Investments Pay Off

2 days ago
Sirius XM Stock

Sirius XM Shares Navigate Volatility Following On-Air Stunt and Board Appointment

2 months ago
Nerdwallet Stock

Why Nerdwallet Stock Remains a Top Analyst Pick Despite Revenue Shortfall

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Satellite Stock Soars on Acquisition Speculation

EOG Shares Face Sustained Downtrend as Key Support Levels Falter

Tradeweb Advances Market Modernization Through Blockchain Initiative and Executive Appointment

Air Products Shares Face Sustained Downturn as Key Support Levels Tested

ITT Shares Maintain Upward Trajectory on Strong Fundamentals

LTC Properties Charts New Course with Strategic Portfolio Overhaul

Trending

ImmunityBio Stock
Analysis

ImmunityBio Shares Face Unrelenting Downward Spiral

by Andreas Sommer
November 4, 2025
0

The biotechnology sector is demonstrating its notoriously unforgiving nature, with ImmunityBio caught in a severe downturn. As...

Raytheon Stock

Raytheon Stock: Record Contracts Signal Strong Growth Trajectory

November 4, 2025
NuCana Stock

NuCana Shares Face Steep Decline Despite Clinical Progress

November 4, 2025
Globalstar Stock

Satellite Stock Soars on Acquisition Speculation

November 4, 2025
EOG Stock

EOG Shares Face Sustained Downtrend as Key Support Levels Falter

November 4, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ImmunityBio Shares Face Unrelenting Downward Spiral
  • Raytheon Stock: Record Contracts Signal Strong Growth Trajectory
  • NuCana Shares Face Steep Decline Despite Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com